Explore DexCom, Inc.'s Q3 2025 financial performance with $1.2B revenue and $283.8M net income. Strong growth trends and a 'Buy' recommendation make this report a must-read.
Explore Dexcom's Q2 2025 financial report highlighting 15.2% revenue growth and a $750M share repurchase plan. A compelling buy for investors in the CGM market.
Explore Dexcom's latest Form 8-K filing detailing significant corporate updates and stock info as of July 25, 2025. Stay informed on DXCM's market activities.
Explore Dexcom, Inc.'s recent 8-K/A filing detailing critical updates from March 6, 2025, vital for investors and market analysts.
Explore Dexcom's Q1 2025 financial performance with a 12.5% revenue growth but declining net income. Key insights for investors on profitability and future strategies.
Explore the latest 8-K filing from Insulet Corporation revealing significant updates for investors. Key details on stock and healthcare focus included.
Discover the latest 8-K filing from Insulet Corporation (PODD) dated March 18, 2025, detailing significant corporate events and stock information for investors.
Discover the latest 8-K report from Insulet Corporation, detailing key updates and stock info as of March 18, 2025. Stay informed on potential investment impacts.
Explore Insulet Corporation's impressive Q4 2024 results, highlighting revenue growth, increased net income, and strategic R&D investments. A must-read for investors!
Explore Insulet Corporation's 8-K filing from February 17, 2025, revealing vital updates for investors. Key info includes stock details, entity info, and effective date.
Explore DexCom, Inc.'s 2024 financial report showcasing impressive revenue growth, effective cost management, and strategic R&D investments in the diabetes management market.
Explore Modular Medical, Inc.'s Q4 2024 report detailing liquidity issues, operating losses, and FDA milestones. Key insights for investors on growth potential and risks.